(Q74272306)

English

The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients

scientific article published on 01 September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Karmochkine

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Si Mohamed

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Piketty

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Ginsburg

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G Raguin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

V Schneider-Fauveau

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L Gutmann

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M D Kazatchkine

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L Belec

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Antiviral Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

179-188

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of drug resistance mutations on virologic response to salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900110-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(00)00110-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974370%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74272306&oldid=1752580356"